Helping you build
better patient profiles
in all phases
of transplantation
Create your personalized experience
Login to see updates, products and resources that matter to you.
Login or Register
Helping you build better patient profiles in all phases of transplantation
Create your personalized experience
Login to see updates, products and resources that matter to you.
Login or Register
Trending Topics
PubSummary
Novel Technology Has Made It Possible To Diagnose A New Clinical Phenotype Of Rejection Called Early Antibody Mediated Rejection, With Significant Therapeutic Implications For Renal Allograft Survival
MMDx Kidney can diagnose ABMR when histopathology is discordant with the clinical scenario. Early Identification may lead to early intervention.
PubSummary
US payer budget impact of a microarray assay with machine learning to evaluate kidney transplant rejection in for-cause biopsies
Dr. Chris Lawrence summarizes how a US payer budget model demonstrates that MMDx Kidney is a cost-effective intervention despite the cost of the assay and the higher treatment costs associated with identifying more rejection.
Patient Resources
Patient Advocacy
To learn about the road to transplant, we've created a docuseries where patient advocate, Valeen Keefer, shares her journey to transplantation. In Episode 5, we learn why emotional and physical support is critical for transplant patients. Valen and Noah share how their caregiver-patient relationship strengthened during their journey.
Community News
Expanding our Transplant Diagnostics Data Management and Analysis Capabilities with HistoTrac Software
We’re excited to combine our software and diagnostic capabilities to streamline the way our customers access, report & manage data, which will ultimately improve transplant outcomes.
Case Study
Case Study | A Challenging Diagnosis in Kidney Transplantation: MMDx Kidney
Divya Raghavan, MD | In a case where a highly sensitized patient received abnormal biopsy results after transplantation, gene expression profiling provided the treating clinician with confirmatory results for diagnosis.
Community News
Transplant Diagnostics Business Makes New Investments in Post-Transplant Technologies
We've partnered with Bio-Techne Corporation and Olaris to develop non-invasive tests that diagnose rejection and support post-transplant monitoring.
Jul
15
Symposia, Webinars, and Workshops
Events
We have events scheduled through October. The next event is the 2022 Texas Transplant Society Scientific Meeting in July.
Recorded Event
Video: UNOS Kidney Allocation: The Evolving Landscape
Cathi Murphey Half | A lab monitored kidney transplant statistics after the March 2021 point-based kidney allocation policy was implemented and used the UNOS kidney simulation model (KPSAM) to assess its predictive value.
Recorded Event
Video: Filling in the gaps: A Single-Center Experience with ExPlex
In this study, a laboratory was able to detect HLA reactivity that would have previously gone undetected in Hispanics without having to perform additional tests, saving time and resources.
Webinar
Recorded Event
Video: Are Dilutions the Solution? Identifying the True Extent of Patient Sensitization
Drs. Mark Stegall and Anat Tambur discuss how serial dilutions of the LABScreen™ Single Antigen assay aid in the assessment of alloantibody levels.
Recorded Event
Video: The Quest for Better Kidney Care in Multicultural Communities
Carolyn of Kidneys Quest Foundation discusses the challenges of dialysis patient care in diverse and underserved communities.
Featured Products & Services
Antibody Detection & Monitoring
LABScreen Single Antigen ExPlex Assay
Our LABScreen™ ExPlex assay provides cutting-edge capabilities with a total of 151 Class I and 119 Class II CWD alleles.
HLA Typing
AllType FASTplex NGS Assay
Our AllType™ FASTplex™ assay offers a complete NGS solution that delivers high-resolution genotyping results.
Antibody Detection & Monitoring
LABScreen Autoantibody Assay
This test characterizes and monitors a broad range of biomarker targets in human sera including vimentin, tubulin, and perlecan (LG3).
Transfusion
Blood Genotyping: Blood typing of ABO, RBC, and HPA
Our real-time PCR genotyping assays automate ABO, RBC, and HPA molecular typing, increasing productivity and turnaround time.
Post-transplant
MMDx: Transplant Biopsy Assessment
MMDx®-Heart and MMDx®-Kidney complement conventional biopsy processing to improve the assessment of rejection and injury in transplanted organs.
© 2022 Thermo Fisher Scientific Inc. All rights reserved.